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ABSTRACT
Objective: Antibiotics revolutionized medicine in the 20th century, and have together with vaccination led to the near eradication of diseases such as 
tuberculosis in the developed world. Their effectiveness and easy access led to overuse, especially in livestock raising, prompting bacteria to develop resistance. 
The lantibiotics form a particular group among the antimicrobial peptides and are characterized by unique structural features. They are produced by a group 
of bacteria against some gram-positive bacteria. The present study was designed to screen for the lantibiotic producing organisms from the hospital samples.
Methods: The bacterial isolates were identified based on Bergey’s manual of bacteriology and screened for the epidermin gene by polymerase chain 
reaction amplification.
Results: Of the 21 isolates screened, only 10 of them showed positive amplification for the epigene. Based on the biochemical characteristics, the 
isolates obtained were identified and labeled.
Conclusion: Further study on the purification of the compound need to be done. Some bacterial samples may not have the epidermin gene which does 
not show amplification, this confers that the epidermin gene is absent in certain organisms.
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INTRODUCTION
Antibiotics, also called antibacterials, are a type of antimicrobial drugs 
used in the treatment and prevention of bacterial infection [1]. They 
may either kill or inhibit the growth of bacteria. A limited number 
of antibiotics also possess antiprotozoal activity. Antibiotics are not 
effective against viruses such as the common cold or influenza, and may 
be harmful when taken inappropriately [2].
The emergence of resistance of bacteria to antibiotics is a common 
phenomenon [3]. Emergence of resistance often reflects evolutionary 
processes that take place during antibiotic therapy [4,5]. The antibiotic 
treatment may select for bacterial strains with physiologically or genetically 
enhanced capacity to survive high doses of antibiotics. Under certain 
conditions, it may result in the preferential growth of resistant bacteria 
while growth of susceptible bacteria is inhibited by the drug. Antibacterial 
resistance may impose a biological cost, thereby reducing fitness of 
resistant strains, which can limit the spread of antibacterial-resistant 
bacteria, for example, in the absence of antibacterial compounds [6-8].
This article treats the terms as synonymous and according to the most 
widespread definition of antibiotics being a substance used against 
bacteria [3,9]. Lantibiotics are a class of peptide antibiotics produced 
by a large number of gram-positive bacteria such as Streptococcus 
and Streptomyces to attack other gram-positive bacteria and contain 
the characteristic polycyclic thioether amino acids lanthionine 
or methyllanthionine, as well as the unsaturated amino acids 
dehydroalanine and 2-aminoisobutyric acid [10]. It is composed of two 
alanine residues that are cross-linked on their β-carbon atoms by a 
thioether (monosulfide) linkage [11].
The lantibiotics are a class of more extensively modified bacteriocins, 
also called Class I bacteriocins [12,13]. (Bacteriocins for which 
disulfide bonds are the only modification to the peptide are Class II 
bacteriocins. Lantibiotics are well studied because of the commercial 
use of these bacteria in the food industry for making dairy products 
such as cheese [14,15]. Nisin and epidermin are members of a family 
of lantibiotics that bind to lipid II, a cell wall precursor lipid component 
of target bacteria and disrupt cell wall production [16]. All lantibiotics 
that have been characterized with respect to the stereochemistry of 
the thioether linkage contain (2S, 6R)-lanthionines, with many family 
members also containing (2S, 3S, 6R)-3-methyllanthionines [17-19]. 
In addition, they generally (but not always) contain the unsaturated 
amino acids 2, 3-dehydroalanine and (Z)-2, 3-dehydrobutyrine [20]. 
In all, no <15 different posttranslational modifications have been 
identified in lantibiotics and it is likely that other modifications remain 
to be discovered. These modifications release the peptides from the 
structural and functional constraints typically imposed on naturally 
occurring ribosomal peptides [21].
The overall mechanism of action of lantibiotic peptides can be phased 
into 3 steps, (1) binding of the peptide to the membrane, (2) insertion 
of the peptide into the membrane, (3) membrane permeabilization [22]. 
Lantibiotics show substantial specificity for some components 
(e. g., lipid II) of bacterial cell membranes, especially of gram-positive 
bacteria. Type A lantibiotics kill rapidly by pore formation, whereas 
Type B lantibiotics inhibit peptidoglycan biosynthesis [23]. Type A 
lantibiotics exert bactericidal activity toward a broad range of 
gram-positive bacterial strains, including Streptococci, Bacillus, Listeriae, 
Clostridia, and Staphylococci. The antibacterial effect is strong: The 
addition of nM concentrations of a lantibiotic is sufficient to kill bacterial 
cells. In contrast, other well-known antibacterial compounds, such as 
melittin, magainin, or cecropin, are active in mM concentrations [24].
Fungal cells, yeast cells, or human cells are very insensitive to 
lantibiotics, even when treated with mM concentrations of the peptides. 
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In general, gram-negative bacteria are also insensitive to lantibiotics. 
It has been shown that their outer membrane functions as a barrier 
for the lantibiotics [25]. When the outer membrane of the gram-
negative strains Escherichia coli or Salmonella species was weakened 
by treatment with ethylenediamine tetraacetic acid (EDTA) or osmotic 
shock, the susceptibility of the cells toward nisin or Pep5 strongly 
increased. The primary target for the activity of the lantibiotics appears 
to be the bacterial cytoplasmic membrane. The peptides interfere with 
the membrane function of sensitive cells by increasing the permeability 
of the bilayer for small molecules and disrupting the membrane 
potential, resulting in cell death. Furthermore, other mechanisms could 
be involved in their biological activity, since it has been reported that 
lantibiotics also inhibit outgrowth of bacterial spores, activate autolytic 
enzymes and might inhibit cell wall biosynthesis [26]. However, these 
mechanisms seem to be secondary effects, since these processes are 
relatively slow and require relatively high concentrations of lantibiotics.
Since the lantibiotics act on the bacterial cytoplasmic-membrane, they 
first have to pass the bacterial cell wall. Many non-lantibiotic bacteriocins, 
such as lactococcin appear to interact with membrane-associated receptor 
proteins, before their membrane perturbing activity. In contrast, a specific 
proteinaceous receptor for lantibiotic species on the outer surface of 
bacteria has not been found so far [27]. This study was designed to isolate 
the strains from hospital environment and to screen for the epidermin 
genes using traditional polymerase chain reaction (PCR).
METHODS
This study was conducted in the Department of Microbiology, Indian 
Academy Degree College. Sampling was done at 5 hospital premises 
(Poly Vista Clinic, Shree Vijay Laxmi Hospital, Cratis Hospital, Avhieta 
Hospital and Good Shepherd Hospital) in and around Bengaluru. 
About 10 samples were collected from each area and then cultured for 
isolation.
Isolation of bacteria from the sample
The samples were serially diluted with sterile distilled water and the 
tubes labeled as 10−3 and 10−4 are plated onto the Mueller Hinton Agar 
medium and then incubated at 37°C for 24 hrs. The colonies obtained 
were further subcultured to obtain pure colonies. The pure colonies 
obtained were used for the experimental study [28].
Biochemical characterization
Isolated bacteria were recultured and identified on basis of Bergey’s 
Manual of Systematic Bacteriology. Gram staining and biochemical 
test such as indole test, sugar utilization test, methyl red test, citrate 
utilization Test, Voges-Proskauer test, starch hydrolysis, catalase test, 
and oxidase test were carried out to find the enzymatic activity of 
isolated organism [29].
DNA isolation
A volume of 2 ml of culture was centrifuged at 8000 rpm, 
10 minutes and the pellet formed was suspended in 567 µl of Tris-
EDTA (TE) buffer. About 30 µl of 10% safety data sheet and 3 µl 
of 20 mg/ml proteinase k was added to the contents and mixed 
thoroughly and incubated for 1 hr at 37°C. 100 µl of 5 M NaCl was 
added and mix thoroughly. The mixture was then added with 80 µl 
hexadecyltrimethlyammonium bromide/NaCl solution and incubated 
for 10 minutes at 65°C. Following incubation, approximately equal 
volume (0.7-0.8 ml) of chloroform/isoamyl alcohol [24:1] was added 
and centrifuged for 8 minutes at 8000 rpm. The aqueous supernatant 
was transferred to a fresh tube and added with equal volume of 
phenol/chloroform/isoamyl alcohol [25:24:1] and the contents were 
spinned down in a microcentrifuge for 5 minutes. 0.6 µl isopropanol 
was added to precipitate the DNA. The pellet was suspended in TE 
buffer until further use.
PCR amplification
The gene selected for the primer designing was epidermin gene with an 
amplicon size of 321 bp. The specific primers were designed using primer 
3 plus software, and the designed oligonucleotides were synthesized in 
sigma corporation USA and ordered from Eurofins, Bangalore. The epi 
gene was amplified by PCR using purified genomic DNA as a template. 
Oligonucleotide primers were synthesized to amplify the intact region 
of epi gene. The forward primer, ATCGATAAGCCATCGCAAGA 3’ and the 
reverse primer, 5’ GTCGTTTGTCGAACATGTGG 3’, were purchased from 
Eurofins, Bangalore. These primers correspond to the gene epi and 
thus, the final PCR product was 321 bp.
The PCR mixture comprised ×10 reaction buffer with MgCl2 (1.5 mM), 
2 µl of dNTP mix (2.5 mM), 2 µl each of forward and reverse primers 
(10 picomoles/µl each primer), 0.3 µl of Taq DNA polymerase (5 U/µl), 
and 50 ng/µl of template DNA in a total volume of 50 µl. The PCR was 
performed with the following cycling profile: Initial denaturation at 
94°C for 2 minutes, followed by 35 cycles of 50 seconds denaturation 
at 94°C, annealing at 55°C for 30 seconds, and extension at 72°C for 
1 minute. The time for the final extension step was increased to 
6 minutes. The PCR products amplified were then qualitatively analyzed 
on 1% agarose gel.
Table 1: Biochemical characteristics of the 10 isolates isolated from sample area 1
Colony Catalase Oxidase Indole MR‑VP Citrate Glucose fermentation Mannitol 
fermentation
Organism
PV1 Negative Negative Negative VP positive Negative Gas formation and 
color change
Negative Aeromonas spp.
PV2 Negative Negative Negative MR positive Negative Negative Gas formation and 
color change
Staphylococcus aureus
PV3 Negative Negative Negative VP positive Negative Gas formation and 
color change
Negative Aeromonas spp.
PV4 Negative Positive Negative VP positive Negative Gas formation and 
color change
Negative Lactobacillus fermenti
PV5 Negative Negative Negative MR positive Negative Negative Gas formation and 
color change
Staphylococcus aureus
PV6 Negative Negative Negative VP positive Negative Color change Color change Lactobacillus casei
PV7 Negative Negative Negative MR positive Negative Negative Gas formation and 
color change
Staphylococcus aureus
PV8 Negative Positive Negative VP positive Negative Gas formation and 
color change
Negative Lactobacillus fermenti
PV9 Negative Negative Negative MR positive Negative Color change Gas formation and 
color change
Lactobacillus casei
PV10 Negative Negative Negative MR positive Negative Color change Color change Lactobacillus casei
MR: Methyl red, VP: Voges-Proskauer, PV: 
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RESULTS AND DISCUSSION
Culture isolates
The bacterial isolates obtained from different sampling areas were 
subcultured and identified based on their cultural characteristics. 
Both Gram-positive and Gram-negative strains were observed from 
the isolates. The biochemical characteristics obtained are shown in 
Tables 1-5 and were identified and labeled.
PCR amplification
A total of 21 bacterial cultures were selected and screened, their 
genomic DNA isolated and amplified through PCR (Fig. 1). Of the 
21 bacterial samples, only 10 showed positive amplification towards 
epidermin gene which are (Staphylococcus aureus, Lactobacillus 
fermenti, Streptococcus sp., Lactobacillus casei, Bacillus badius, Bacillus 
larvae, S. aureus, B. popilliae, Bacillus megaterium, Bacillus sp.). From 
10 bacterial cultures, 5 organisms showed maximum amplification 
for epidermin gene (L. fermenti, Streptococcus sp., B. badius, B. larvae, 
Bacillus sp.).
DISCUSSION
Antibiotic resistance in bacteria is high and is increasing in many 
countries worldwide causing great concern for public health [30]. 
During the past decade, there have been an increasing number of 
reports both antibiotic and antibiotic resistance genes in different 
environmental settings. Antibiotic resistant bacteria and genes 
encoding antibiotic resistance are commonly detected in wastewater, 
often at higher rates and concentrations compared to surface 
water [31]. Wastewater can also provide favorable conditions for the 
growth of a diverse bacterial community, which constitutes a basis for 
the selection and spread of antibiotic resistance. Wastewater samples 
were collected and organisms were isolated which are process for DNA 
isolation without any contamination of RNA. Further, it is processed 
for PCR amplification. A total of 21 samples were processed for PCR 
Table 2: Biochemical characteristics of the 10 isolates isolated from sample area 2
Colony Catalase Oxidase Indole MR‑VP Citrate Mannitol fermentation Starch hydrolysis Organism
SVL1 Negative Positive Negative MR positive Negative Negative Positive Bacillus hadius
SVL2 Negative Positive Negative VP positive Negative Negative Negative Bacillus larvae
SVL3 Negative Positive Negative MR positive Negative Negative Positive Bacillus hadius
SVL4 Negative Negative Negative VP positive Positive Negative Positive Bacillus licheniformis
SVL5 Negative Negative Negative VP positive Negative Negative Positive Bacillus pohmyxa
SVL 6 Negative Positive Negative VP positive Negative Color change Negative Bacillus larvae
SVL7 Negative Positive Negative VP positive Positive Negative Positive Bacillus coagulans
SVL8 Negative Positive Negative VP positive Negative Negative Positive Bacillus coagulans
SVL9 Negative Negative Negative MR positive Positive Negative Positive Bacillus megaterium
SVL10 Negative Positive Negative MR positive Positive Negative Negative Bacillus azotoformans
Table 3: Biochemical characteristics of the 10 isolates isolated from sample area 3
Colony Catalase Oxidase Indole MR‑VP Citrate Mannitol fermentation Starch hydrolysis Organism
CR1 Negative Positive Negative VP positive Positive Negative Positive Bacillus coagulans
CR2 Negative Positive Negative VP positive Positive Negative Negative Bacillus azotoformans
CR3 Negative Positive Negative VP positive Negative Colour change Negative Streptococcus spp.
CR4 Negative Negative Negative VP positive Negative Negative Positive Bacillus sp.
CR5 Negative Positive Negative VP positive Positive Negative Positive Bacillus coagulans
CR6 Negative Positive Negative VP positive Positive Negative Positive Bacillus coagulans
CR7 Negative Positive Negative VP positive Positive Negative Positive Bacillus coagulans
CR8 Negative Negative Negative VP positive Negative Negative Negative Bacillus sp.
CR9 Negative Positive Negative MR positive Positive Negative Negative Bacillus azotoformans
CR10 Negative Positive Negative VP positive Positive Negative positive Bacillus coagulans
MR: Methyl red, VP: Voges-Proskauer, CR: ???
Table 4: Biochemical characteristics of the 10 isolates isolated from sample area 4







AVI Negative Negative Negative VP positive Negative Negative Negative Negative Bacillus sp.
AV2 Negative Positive Negative VP positive Negative Color change Negative Negative Aeromonas spp.
AV3 Negative Negative Negative MR positive Negative Negative Negative Negative Bacillus popilliae
AV4 Negative Positive Negative VP positive Negative Negative color change Positive Lactobacillus casei
AV5 Negative Negative Negative VP positive Negative Negative Negative Positive Bacillus polymyxa
AV6 Negative Positive Negative VP positive Negative Negative Negative Positive Streptococcus sp.
AV7 Negative Positive Negative MR positive Negative Negative Negative Positive Bacillus badius
AY8 Negative Negative Negative MR positive Negative Negative Negative Positive Bacillus badius
AY9 Negative Positive Negative MR positive Positive Negative Negative Positive Bacillus megaterium
AV10 Negative Negative Negative MR positive Positive Negative Negative Negative Bacillus azotoformans
MR: Methyl red, VP: Voges-Proskauer, AV: ???
Fig. 1: Left: Gel showing the polymerase chain reaction 
amplification of epi gene on 2% agarose gel. Molecular 
marker (100 bp) is used. Lane 1: Staphylococcus aureus, Lane 
2: Lactobacillus fermenti, Lane 3: Streptococcus sp. Lane 4: 
Lactobacillus casei, Lane 5: Bacillus badius; Right: Lane 1: 
Bacillus larvae, Lane 2: S. aureus, Lane 3: Bacillus popilliae, 
Lane 4: Bacillus megaterium, Lane 5: Bacillus sp
MR: Methyl red, VP: Voges-Proskauer, SVL: ???
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amplification out of which 10 isolates showed positive amplification. 
Totally 5 organisms gave maximum amplification for epidermin gene. 
Some bacterial samples may not have the epidermin gene which does 
not show amplification this confers that the epidermin gene is absent 
in certain organisms. Further the experiment can be planned to purify 
the compound of interest and use it as an antibacterial against certain 
gram-positive organisms.
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